• Je něco špatně v tomto záznamu ?

Inflammatory biomarkers and liver histopathology in non-uremic and uremic chronic hepatitis C patients

B. Tatar, S. Kose, E. Pala, E. Tatar

. 2017 ; 60 (2) : 71-75.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18021083

BACKGROUND: The aim of this study is to investigate the association between hepatic activity index (HAI) and fibrosis score (FS) with inflammation biomarkers in non-uremic and uremic hepatitis C positive patients. METHODS: Fifty chronic hepatitis C (cHepC) positive patients, having a liver biopsy were included in this study. Liver biopsies were scored according to modified ISHAC scoring system. 25 healthy controls of similar age and gender were also enrolled as control group. Serum YKL-40, neutrophil/lymphocyte ratio (NLR), thrombocyte/lymphocyte ratio (PLR), CRP and Immunoglobulin (IgG, A and M) levels were used to determine inflammation. AST to Platelet Ratio Index (APRI) score was also evaluated. According to biopsy findings patients were divided into 2 groups: low (0-2) and severe (3-6) FS. RESULTS: Patients with cHepC had increased inflammation compared to the healthy controls. End-stage renal disease (ESRD) patients had higher levels of inflammation markers (NLR, IgG, CRP and YKL-40) and lower HCV RNA levels, HAI and FS compared to non-uremic patients. When patients were grouped into 2 according to FS as mild and severe, IgG (p < 0.001), YKL-40 (p = 0.02) levels and APRI score (p = 0.002) were significantly higher compared to mild FS (p = 0.002). YKL-40 levels (t value: 3.48; p = 0.001) and APRI score (t value: 4.57, p < 0.001) were found as independent associated with FS in non-uremic patients. However, in adjusted models, only APRI score (t value: 3.98, p = 0.002) was an independent associated with FS in ESRD patients. CONCLUSION: In non-uremic cHepC patients, YKL-40 levels and APRI score may be valuable markers of FS. In ESRD patients, there is not sufficient data for prediction of HAI and FS. In these patients, APRI score may provide better information.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18021083
003      
CZ-PrNML
005      
20180621133822.0
007      
ta
008      
180611s2017 xr f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2017.96 $2 doi
035    __
$a (PubMed)28976873
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Tatar, Bengu $u University of Health Science, Izmir Tepecik Education and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Izmir, Turkey
245    10
$a Inflammatory biomarkers and liver histopathology in non-uremic and uremic chronic hepatitis C patients / $c B. Tatar, S. Kose, E. Pala, E. Tatar
520    9_
$a BACKGROUND: The aim of this study is to investigate the association between hepatic activity index (HAI) and fibrosis score (FS) with inflammation biomarkers in non-uremic and uremic hepatitis C positive patients. METHODS: Fifty chronic hepatitis C (cHepC) positive patients, having a liver biopsy were included in this study. Liver biopsies were scored according to modified ISHAC scoring system. 25 healthy controls of similar age and gender were also enrolled as control group. Serum YKL-40, neutrophil/lymphocyte ratio (NLR), thrombocyte/lymphocyte ratio (PLR), CRP and Immunoglobulin (IgG, A and M) levels were used to determine inflammation. AST to Platelet Ratio Index (APRI) score was also evaluated. According to biopsy findings patients were divided into 2 groups: low (0-2) and severe (3-6) FS. RESULTS: Patients with cHepC had increased inflammation compared to the healthy controls. End-stage renal disease (ESRD) patients had higher levels of inflammation markers (NLR, IgG, CRP and YKL-40) and lower HCV RNA levels, HAI and FS compared to non-uremic patients. When patients were grouped into 2 according to FS as mild and severe, IgG (p < 0.001), YKL-40 (p = 0.02) levels and APRI score (p = 0.002) were significantly higher compared to mild FS (p = 0.002). YKL-40 levels (t value: 3.48; p = 0.001) and APRI score (t value: 4.57, p < 0.001) were found as independent associated with FS in non-uremic patients. However, in adjusted models, only APRI score (t value: 3.98, p = 0.002) was an independent associated with FS in ESRD patients. CONCLUSION: In non-uremic cHepC patients, YKL-40 levels and APRI score may be valuable markers of FS. In ESRD patients, there is not sufficient data for prediction of HAI and FS. In these patients, APRI score may provide better information.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a biopsie $7 D001706
650    _2
$a trombocyty $x metabolismus $7 D001792
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a protein CHI3L1 $x krev $7 D000071451
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a chronická hepatitida C $x patofyziologie $7 D019698
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x patofyziologie $7 D007249
650    _2
$a počet leukocytů $7 D007958
650    _2
$a játra $x patologie $7 D008099
650    _2
$a počet lymfocytů $7 D018655
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neutrofily $x metabolismus $7 D009504
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a uremie $x komplikace $7 D014511
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kose, Sukran $u University of Health Science, Izmir Tepecik Education and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Izmir, Turkey
700    1_
$a Pala, Emel $u University of Health Science, Izmir Tepecik Education and Research Hospital, Pathology, Izmir, Turkey
700    1_
$a Tatar, Erhan $u University of Health Science, Izmir Bozyaka Education and Research Hospital, Department of Nephrology, Izmir, Turkey
773    0_
$w MED00010947 $t Acta Medica (Hradec Kralove) $x 1211-4286 $g Roč. 60, č. 2 (2017), s. 71-75
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28976873 $y Pubmed
856    41
$u https://actamedica.lfhk.cuni.cz/media/pdf/am_2017060020071.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 3077 $c 1072 $y 4 $z 0
990    __
$a 20180611 $b ABA008
991    __
$a 20180619074831 $b ABA008
999    __
$a ok $b bmc $g 1311790 $s 1017955
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 60 $c 2 $d 71-75 $i 1211-4286 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
LZP    __
$b NLK118 $a Pubmed-20180611

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...